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Introduction {#sec001}
============

To generate desired transgenic plants, both transgenes that confer the desired traits and promoters that instruct expression of transgene in targeted tissues are needed \[[@pone.0230203.ref001],[@pone.0230203.ref002]\]. Constitutive promoters, such as cauliflower mosaic virus 35S (CaMV35S) \[[@pone.0230203.ref003]\], maize ubiquitin \[[@pone.0230203.ref004]\], and rice actin promoters \[[@pone.0230203.ref005]\] have been widely used in both basic and applied studies. Among these, the CaMV35S promoter is the most frequently used one \[[@pone.0230203.ref001],[@pone.0230203.ref006],[@pone.0230203.ref007]\]. However, in many cases high and universal expression of target genes is nutrient and energy consuming. Moreover, constitutive expression of some genes can produce negative impacts on plant growth or agronomic performance \[[@pone.0230203.ref008]--[@pone.0230203.ref010]\].

Tissue-specific promoters allow the expression of targeted genes only in specific tissues \[[@pone.0230203.ref011],[@pone.0230203.ref012]\]. Reproductive tissues (*e*.*g*., flower and seed) are frequent targets for transgene expression to improve yield or commercial value of plants \[[@pone.0230203.ref013]--[@pone.0230203.ref015]\]. Thus far, many flower specific promoters have been isolated and characterized. However, such promoters often have some drawbacks for applications, *e*.*g*., low activity or non-specific leakage \[[@pone.0230203.ref001],[@pone.0230203.ref010]\]. To increase expression of target genes or to avoid homology-based gene silencing, a variety of strategies have been proposed, such as dCas9-based gene activation tool \[[@pone.0230203.ref016]\], codon optimization \[[@pone.0230203.ref017]\], synthetic promoters \[[@pone.0230203.ref002]\]. Among them, chimeric or synthetic promoter capable of directing gene expression with desired strength in right tissue or right developmental stage of plants is a simple one. Enhancer is a *cis*-acting DNA sequence that can stimulate transcription from proximal promoters in a distance- and orientation-independent manner \[[@pone.0230203.ref018],[@pone.0230203.ref019]\]. To increase the activity of tissue-specific promoters, a simple and straightforward strategy is fusing an enhancer to the promoter.

*AGAMOUS* (*AG*) is a MADS-box gene that acts in the inner two whorls of [*A*]{.ul}*rabidopsis* [*t*]{.ul}*haliana* flowers to specify stamens and carpels \[[@pone.0230203.ref020],[@pone.0230203.ref021]\]. The expression of *AG* is strictly confined to carpel and stamen primordia and tissues \[[@pone.0230203.ref022],[@pone.0230203.ref023]\]. It has been shown that the second intron/enhancer (AGI) of *AG* is responsible for conferring the tissue specificity of the gene \[[@pone.0230203.ref024]\]. In transgenic Arabidopsis, *AG* native promoter alone drives GUS expression in both vegetative and floral tissues. With the presence of the second intron/enhancer, GUS expression is specifically localized to carpels and stamens \[[@pone.0230203.ref025]\]. Furthermore, artificial promoter generated by fusing AtAGI to the minimal 35S promoter (AtAGIP) is sufficient to drive gene expression precisely in carpels and stamens \[[@pone.0230203.ref026],[@pone.0230203.ref027]\]. Yang and colleagues (2010) isolated two similar *AG* second intron/enhancers, NtAGI-1 and NtAGI-2, from tetraploid tobacco ([*N*]{.ul}*icotiana* [*t*]{.ul}*abacum*). Fusing them to the minimal 35S promoter, they generated NtAGIP1 and NtAGIP2 promoters. Like AtAGIP, the two promoters are able to drive carpel- and stamen-specific expression without any leaky activity in vegetative tissues \[[@pone.0230203.ref028]\].

To increase the activity of NtAGIP1, in this study, we added a 35S enhancer to the promoter. The enhancer significantly increased the promoter activity. Interestingly, although extended to sepals and pedicles, the activity of the new promoter was still confined to the inflorescence. We showed that the -2835 to -2735 region of NtAGI-1 which contains a conserved GAGA factor binding motif can suppress the activity of 35S enhancer in vegetative tissues by mediating histone H3 lysine 27 trimethylation (H3K27me3) modification of the promoter. Our results provide useful information for the improvement of tissue-specific promoters, and the resultant 35SNtAGIP1 promoter can be used in transgenic plants when strong expression of target gene in flowers is required.

Materials and methods {#sec002}
=====================

Plant material and growth condition {#sec003}
-----------------------------------

Common tobacco, *Nicotiana tabacum* cv. *Xanthi*, was used in this study. Tobacco plants were grown on soil in a greenhouse under natural day length conditions. To generate sterilized plantlets for transformation, seeds were first surface-sterilized, and then germinated on MS solid medium supplemented with 30% sucrose. The seed sterilization process consists of 75% ethanol 1 min; 1% sodium hypochlorite (NaOCl) 15 min; wash 6--8 times with sterilized water. Plated seeds were germinated and grown in a growth chamber under a 16 h light and 8 h dark photoperiod at 28°C.

Plasmid construction {#sec004}
--------------------

The plasmid pBI121 \[[@pone.0230203.ref029]\] that contain *CaMV35S*::*GUS* was used as backbone to construct vectors used for plant transformation in this study. The second intron of *NtAG-1* gene was fused with a 45 bp minimal 35S promoter to create a functional NtAGIP1 promoter \[[@pone.0230203.ref028]\]. *NtAGIP1*::*GUS* vector was constructed by replacing the CaMV35S promoter of pBI121 using *Sal*I and *Bam*HI restriction sites. For constructing *35SNtAGIP1*::*GUS* vector, the 35S enhancer (-396 to -46) was added at the 5' end of NtAGIP1 using *Sal*I and *Spe*I restriction sites that had been introduced during the construction of *NtAGIP1*::*GUS* vector. For generating *Promoterless*::*GUS* vector, the CaMV35S promoter of pBI121 was deleted by *Sal*I and *Bam*HI restriction enzymes.

For serial deletions of the NtAGI-1, shortened NtAGIP1 sequences were PCR amplified with the PrimeSTAR Max DNA Polymerase (Takara) using primers listed in the [S1 Table](#pone.0230203.s001){ref-type="supplementary-material"}. Each shortened version of NtAGIP1 had *Spe*I and *Bam*HI restriction sites. Then, the fragments are cloned into the *Spe*I/*Bam*HI-digested *35SNtAGIP1*::*GUS* plasmid, resulting in replacing the full length NtAGIP1 with the shortened NtAGIP1 sequences.

To test the inhibitory effect of the 100-bp repressive fragment of NtAGI-1, the three promoters, 35SRF, 35SUC and 35SDC, were synthesized directly, and then fused to upstream of *GUS* gene in the pBI121 plasmid using *Sal*I and *Bam*HI restriction sites, generating *35SRF*::*GUS*, *35SUC*::*GUS* and *35SDC*::*GUS* vectors.

Plant transformation {#sec005}
--------------------

The resulting plasmids were introduced into *Agrobacterium tumefaciens* (LBA4404) by electroporation. Leaf disc transformation of tobacco using the *Agrobacterium tumefaciens* was performed as previously described \[[@pone.0230203.ref030]\]. Briefly, bacteria grown in YEB for 20 h were harvested by centrifugation and resuspended to an OD~600~ of 0.8--1.0 in MS medium supplemented with 10 g/L sucrose. Aseptic leaves were cut into pieces (around 6 mm in diameter) and the leaf discs were inoculated with the bacterial suspension for 30 min, blotted on sterile filter paper, and then transferred to co-cultivation medium (MS salt containing vitamins, 2.0 mg/L 6-BA, 0.5 mg/L NAA, 10 g/L sucrose, 2.0 g/L Gelrite, pH 5.4). After maintained at 25°C in the dark for 2 days, the transformed leaf discs were transferred onto selection medium Ⅰ (MS salt containing vitamins, 2.0 mg/L 6-BA, 0.5 mg/L NAA, 200 mg/L cephalosporin, 50 mg/L kanamycin, 30 g/L sucrose, 2.0 g/L Gelrite, pH 5.8). When visible calli appeared on explants, the cultures were transferred to selection medium Ⅱ (MS salt containing vitamins, 200 mg/L cephalosporin, 50 mg/L kanamycin, 30 g/L sucrose 2.0 g/L Gelrite, pH 5.8) for shoots production and root elongation. Kanamycin-resistant candidate transgenic plants were verified by PCR amplifying the *NptII* gene with 2×Taq Master Mix (Novoprotein, China), and then were transplanted and grown in the greenhouse.

Histochemical detection and microscopy {#sec006}
--------------------------------------

Histochemical assay of GUS activity was performed as described previously \[[@pone.0230203.ref029]\]. Detached or hand-sectioned tissues were incubated in GUS staining solution (1 mM X-Gluc in 100 mM sodium phosphate (pH 7.0), 0.5 mM K~4~\[Fe(CN)~6~\], 0.5 mM K~3~\[Fe(CN)~6~\], and 0.1% Triton X-100, 10 mM EDTA-Na~2~) at 37°C in the dark overnight. Then, the tissues were bleached with 95% ethanol before photographing. Microscopic observation was performed with OLYMPUS-MVX10 microscope (Olympus). Images were captured with Image Pro-Plus software (Media Cybernetics).

Fluorometric assays of GUS activity {#sec007}
-----------------------------------

Fluorometric assay of GUS activity was conducted as described by Jefferson et al \[[@pone.0230203.ref029]\]. Four lines with strong GUS staining signal of *NtAGIP1*::*GUS* and *35SNtAGIP1*::*GUS* transgenic tobaccos, and all lines of *35SRF*::*GUS*, *35SUC*::*GUS* and *35SDC*::*GUS* transgenic tobaccos were used for the assay. Tissues were ground in liquid nitrogen with mortar and pestle and homogenized in extracting buffer (50 mmol/L sodium phosphate buffer containing 100 mg/mL PVPP and 10 mmol/L β-mercaptoethanol, PH 7.0). After incubation on ice for 1 h, the extraction mixture was centrifuged at 15000×g for 10 min. The supernatant was used for GUS activity assay in which 20 μL supernatant was mixed with 50 μL assay buffer containing 1.4 mM 4-methylumbelliferone (4-MU) (Sigma). The reaction was incubated at 37°C for 30 min and then stopped with 130 μL stop solution containing 200 mM sodium carbonate. The liberation of 4-MU was detected by measuring the fluorescence on a microplate reader (TECAN infinite M200 PRO) with excitation at 365 nm and emission at 455 nm and standardized against known concentrations of 4-MU diluted in the buffer. The protein concentration was determined by the Bradford assay \[[@pone.0230203.ref031]\], using bovine serum albumin as the standard. GUS activity was calculated as nmol 4-MU/min/mg protein and each test was performed with three biological replicates.

H3K27me3 chromatin immunoprecipitation (ChIP) {#sec008}
---------------------------------------------

Tobacco leaves (0.8--1.0 g fresh weight) were harvested and used for the H3K27me3 ChIP assay. ChIP was performed with EpiQuik^TM^ Plant ChIP Kit (Epigentek, [http://www.epigentek.com](http://www.epigentek.com/)) following the manufacturer's instructions. The anti-H3K27me3 antibody (Millipore, [http://www.emdmillipore.com](http://www.emdmillipore.com/)) was used for immunoprecipitation. 2.0 μL of immunoprecipitated DNA was used for qRT-PCR experiments. Primers used for the qRT-PCR detection are listed in the [S2 Table](#pone.0230203.s002){ref-type="supplementary-material"}. qRT-PCR was performed with 1×iQ^™^ SYBR Green Supermix (Bio-Rad) on CFX96TM Real-Time System (Bio-Rad). The thermal cycling consisted of an initial denaturation (94°C, 3 min) followed by 40 cycles (94°C, 20 s; 56°C, 20 s; 72°C, 30 s). ChIP assays were performed with three biological replicates.

Statistical analysis {#sec009}
--------------------

Data were statistically analyzed by Microsoft Excel. Means and standard deviations (SD) of values are shown. Statistical comparison was analyzed with two-tailed Student's *t*-test, and indicated by asterisks (\*, *P* \< 0.001) or NS (NS, not significant, *P* \> 0.05).

Results {#sec010}
=======

Adding 35S enhancer to NtAGIP1 broadens the tissue specificity from carpels and stamens to whole inflorescence {#sec011}
--------------------------------------------------------------------------------------------------------------

To increase the promoter activity, we added 35S enhancer fragment (-396 to -46) \[[@pone.0230203.ref032],[@pone.0230203.ref033]\] to the 5 'end of NtAGIP1, and generated 35SNtAGIP1 promoter ([Fig 1A](#pone.0230203.g001){ref-type="fig"}). Then, NtAGIP1 and 35SNtAGIP1 were fused to the *GUS* coding region to create *NtAGIP1*::*GUS* and *35SNtAGIP1*::*GUS* fusions ([Fig 1A](#pone.0230203.g001){ref-type="fig"}). *CaMV35S*::*GUS* and *Promoterless*::*GUS* were used as positive and negative controls, respectively ([Fig 1A](#pone.0230203.g001){ref-type="fig"}). The four expressing vectors were used to generate transgenic tobaccos through *Agrobacterium*-mediated transformation using kanamycin resistant *NptII* gene as the selectable marker. Putative transformants were verified by PCR detection, and the positive transformants were selected for studies.

![Adding 35S enhancer broadens the tissue specificity of NtAGIP1 in inflorescence.\
(**A**) Schematic diagram of constructs based on binary vector pBI121 for the synthetic promoter assays. (**B-E**) Expression patterns of *GUS* gene driven by different promoters in (A). Representative GUS patterns are shown for *NtAGIP1*::*GUS* (B), *35SNtAGIP1*::*GUS* (C), *CaMV35S*::*GUS* (D), and *Promoterless*::*GUS* (E) in transgenic reporter lines. Independent transgenic lines (n \> 20 for each construct) were assayed for GUS expression in inflorescences, leaves, stems and roots. Scale bars, 1 mm.](pone.0230203.g001){#pone.0230203.g001}

Histochemical analysis of GUS activity was performed to examine the expression pattern driven by the promoters ([Fig 1B--1E](#pone.0230203.g001){ref-type="fig"}). *CaMV35S*::*GUS* lines, the positive control, exhibited strong GUS staining in all vegetative tissues, including leave, stem, and root tissues. Consistent with previous report \[[@pone.0230203.ref028]\], GUS activity in *NtAGIP1*::*GUS* line was observed only in stamens and carpels. Interestingly, adding 35S enhancer to the 5' end of NtAGIP1, the activity of the promoter was observed not only in stamens and carpels, but also in sepals and pedicels ([Fig 1B--1E](#pone.0230203.g001){ref-type="fig"}), indicating that adding 35S enhancer broadens the tissue-specificity in carpels and stamens to the whole inflorescence. Nevertheless, no GUS signal was observed in the vegetative tissues including roots, stems and leaves of *35SNtAGIP1*::*GUS* lines.

Adding 35S enhancer to NtAGIP1 increases the promoter activity {#sec012}
--------------------------------------------------------------

We noted that compared with NtAGIP1, adding the 35S enhancer also increased the activity of NtAGIP1 promoter. Based on the intensity of GUS staining, transgenic lines were classified into four groups: strong, intermediate, weak, and no staining ([Fig 2A](#pone.0230203.g002){ref-type="fig"}). In *NtAGIP1*::*GUS* lines (n = 27) tested, 15%, 11%, 19%, and 55% lines displayed strong, intermediate, weak, and no staining respectively. While in *35SNtAGIP1*::*GUS* lines (n = 37), the proportion of strong, intermediate, weak, and no staining was 46%, 19%, 16%, and 19% respectively ([Fig 2B](#pone.0230203.g002){ref-type="fig"}). Quantification of GUS activity of the four strong expressing lines of each group confirmed that the gene expression in the inflorescence and inner whorls of flowers of *35SNtAGIP1*::*GUS* lines was much higher than that of *NtAGIP1*::*GUS* lines ([Fig 3](#pone.0230203.g003){ref-type="fig"}). The data indicate that adding the 35S enhancer can remarkably enhance the activity of NtAGIP1 promoter in inflorescent tissues.

![Adding 35S enhancer increased the promoter activity.\
(**A**) Examples of strong, weak, intermediate, and no GUS staining in inflorescence of *NtAGIP1*::*GUS* and *35SNtAGIP1*::*GUS* lines. Scale bars, 1 mm. (**B**) Statistics of lines showing strong, intermediate, weak, or no GUS staining in inflorescence of *NtAGIP1*::*GUS* and *35SNtAGIP1*::*GUS* transgenic tobaccos.](pone.0230203.g002){#pone.0230203.g002}

![Adding 35S enhancer enhanced the GUS activity in the inflorescence.\
GUS activity in the inflorescence (**A**), and in inner whorls of the flower (**B**). Four lines of *NtAGIP1*::*GUS* and *35SNtAGIP1*::*GUS* transgenic tobaccos with strong GUS expression were selected randomly for GUS activity assays. Error bars represent standard deviations of three biological replicates. \*, *P* \< 0.001; NS, not significant (*P* \> 0.05) relative to \#6 line of *NtAGIP1*::*GUS* tobacco; two-tailed Student's *t*-test.](pone.0230203.g003){#pone.0230203.g003}

The -2835 to -2735 region of NtAGIP1 contributes to the suppression of vegetative expression {#sec013}
--------------------------------------------------------------------------------------------

Now the question is why adding the 35S enhancer can enhance the activity of NtAGIP1 promoter but not impair its specificity in the reproductive organs. To answer it, a progressive deletion of full length NtAGIP1 (\~4.2kb) promoter was performed. Each shortened sequence was fused with 35S enhancer at its 5' end and then linked to *GUS* reporter gene ([Fig 4A](#pone.0230203.g004){ref-type="fig"}). The resultant constructs were delivered into tobacco, respectively. GUS expression in leaves of more than 30 transgenic lines for each construct was detected and the expression frequency was calculated ([Fig 4A](#pone.0230203.g004){ref-type="fig"}). When the deletion reached to the upstream -2835, almost no GUS expression was observed in leaves. However, when the deletion arrived at -2365 and thereafter, GUS expression was significantly detected in the populations. In -2365 construct, the GUS expression frequency was 36.3%, and further deletion had no more significant effect on the GUS expression frequency. These results suggested that putative repressive elements exist between -2835 and -2365. To characterize the location of potential repressive elements between -2835 and -2365, we conducted a new series of deletion by every 100 bp. When the deletion extended to -2735, GUS expression was observed in 9 out of 31 lines. Further deletion to -2635, -2535, and -2435 did not result in a significant increase of the GUS expression frequency ([Fig 4B](#pone.0230203.g004){ref-type="fig"}). These results firmly demonstrate that putative repressive elements locate in the 100-bp region between -2835 and -2735 of NtAGI-1.

![Dissection analysis of the *NtAG* intron to dig potential repressive elements.\
(**A**) Schematic diagram of constructs of serial deletions of NtAGIP1 (left), and GUS expression frequency in leaves of transgenic tobacco lines for each construct (right). (**B**) Further serial deletions of fragment between -2835 and -2365 for precise localization of potential repressive elements (left), and GUS expression frequency in leaves of transgenic tobacco lines for each construct (right).](pone.0230203.g004){#pone.0230203.g004}

The -2835 to -2735 region of NtAGI-1 can repress the vegetative activity of 35S enhancer {#sec014}
----------------------------------------------------------------------------------------

To test the repressive role of the -2835 to -2735 fragment of NtAGI-1 in the vegetative expression, we fused the fragment between the 3' end of the 35S enhancer and 5' end of the 35S minimal promoter, and then generated 35SRF (Repressive Fragment) promoter ([Fig 5A](#pone.0230203.g005){ref-type="fig"}). Two 100-bp DNA fragments (-2934 to -2834 and -2736 to -2636) from up- and down-stream of the repressive fragment were used as controls to generate promoters 35SUC (Upstream Control) and 35SDC (Downstream Control), respectively ([Fig 5A](#pone.0230203.g005){ref-type="fig"}). The promoters were fused to *GUS* gene respectively, and then transgenic *35SRF*::*GUS*, *35SUC*::*GUS*, and *35SDC*::*GUS* tobaccos were generated. GUS staining showed that 86.7% (26/30) of *35SUC*::*GUS*, and 88.5% (23/26) of *35SDC*::*GUS* reporter lines showed obvious GUS expression in leaves. In contrast, 50.0% (17/34) of *35SRF*::*GUS* lines showed detectable GUS signal in leaves ([Fig 5B](#pone.0230203.g005){ref-type="fig"}). Noticeably, GUS activity in leaves of *35SRF*::*GUS* lines was significantly lower than (*P* \< 0.001) that of *35SUC*::*GUS* and *35SDC*::*GUS* lines ([Fig 5C](#pone.0230203.g005){ref-type="fig"}). The data indicate that the -2835 to -2735 repressive fragment of NtAGI-1 has ability to repress activity of the constitutive enhancer in the vegetative tissue.

![The 100-bp repressive fragment of NtAGI-1 is able to suppress 35S enhancer activity in leaves.\
(**A**) Schematic diagram of *GUS* reporter constructs. (**B**) GUS expression frequency driven by the chimeric promoter containing 35S enhancer and the 100-bp repressive fragment and by two control promoters. (**C**) Quantification of GUS activity in the three transgenic groups. Statistical significance was determined by two-tailed Student's *t*-test. The horizontal lines represent the medians.](pone.0230203.g005){#pone.0230203.g005}

The -2835 to -2735 region of NtAGI-1contains GAGA factor binding motif {#sec015}
----------------------------------------------------------------------

Bioinformatic analysis result showed that in the -2835 to -2735 region of NtAGI-1 there was a GAGA factor binding motif ([Fig 6](#pone.0230203.g006){ref-type="fig"}) that is involved in the recruitment of polycomb repressive complex 2 (PRC2) \[[@pone.0230203.ref034]--[@pone.0230203.ref036]\]. PRC2 is responsible for the repression of flower genes, including *AG*, in vegetative tissues. Interestingly, all *AG* homologs of the five Solanaceae plants, tobacco, tomato, potato, petunia and pepper, have a big second intron ([Fig 7](#pone.0230203.g007){ref-type="fig"}), in which the 100-bp repressive fragment of NtAGI-1 with GAGA factor binding motif is conserved among the species of Solanaceae family ([Fig 6](#pone.0230203.g006){ref-type="fig"} and [Table 1](#pone.0230203.t001){ref-type="table"}).

![The 100-bp repressive fragment (orange line) and GAGA motif (red triangles) of NtAGI-1 are conserved in the species of Solanaceae family.](pone.0230203.g006){#pone.0230203.g006}

![Structure of *AG* homologous genes in different plant species.\
Grey boxes indicate non-coding regions, black boxes represent coding regions, and lines indicate introns.](pone.0230203.g007){#pone.0230203.g007}

10.1371/journal.pone.0230203.t001

###### Comparison of *N*.*tabacum AG* second intron with those from other plants.

![](pone.0230203.t001){#pone.0230203.t001g}

  Solanaceae species                      Percent identity with *N*.*tabacum*   GenBank accession of *AG* homolog
  --------------------------------------- ------------------------------------- -----------------------------------
  *Petunia x hybrida* (petunia)           69.5                                  AB076051.1
  *Solanum tuberosum* (potato)            58.1                                  NW_006239189.1
  *Solanum lycopersicum* (tomato)         57.3                                  NC_015439.3
  *Capsicum annuum* (pepper)              58.3                                  NC_029978.1
  Non-Solanaceae species                                                        
  *Arabidopsis thaliana* (Brassicaceae)   48.6                                  NC_003075.7
  *Zea mays* (maize; Poaceae)             44.0                                  NC_024466.2

It has been known that PRC2-mediated repression of flower genes is resulted from H3K27me3 modification to form epigenetically stable silent chromatin state \[[@pone.0230203.ref037],[@pone.0230203.ref038]\]. Our chromatin immunoprecipitation (ChIP) assay showed that in the wild-type tobacco the entire NtAGI-1 intron including the 100-bp repressive fragment was enriched for H3K27me3 modification ([Fig 8A](#pone.0230203.g008){ref-type="fig"}). In the GUS positive -2735 cells, H3K27me3 level of the chimeric promoter was much lower than that in the GUS negative -2835 cells ([Fig 8B](#pone.0230203.g008){ref-type="fig"}), indicating that the 100-bp region can mediate H3K27 tri-methylation to suppress the activity of the promoter. These results suggest the crucial role of GAGA motif in the 100-bp region for the vegetative repression.

![ChIP assay for H3K27me3 levels in NtAGI-1 intron and chimeric promoters.\
(**A**) ChIP assay for H3K27me3 levels at the NtAGI-1 intron in leaves of wild-type tobacco. (**B**) ChIP assay for H3K27me3 levels in leaves of the -2835 and -2735 lines. The genomic fragment from immunoprecipitation for qRT-PCR detection is depicted as black horizontal line. Enrichment was represented as percentage of Input (% Input). Error bars represent the standard deviation of three biological replicates.](pone.0230203.g008){#pone.0230203.g008}

Discussion {#sec016}
==========

It is often a dilemma when design a strong tissue-specific promoter: increasing the strength of the promoter is frequently accompanied by the loss of tissue specificity. In this study, we show that the well-known strong enhancer (-396 to -46) of 35S promoter can be harnessed for the design of the chimeric flower-specific promoter by fusing it with the floral organ-specific promoter NtAGIP1. The strength of the promoter in the flower is significantly enhanced. Meanwhile, its activity is confined to the reproductive organs. We further demonstrate that a 100-bp repressive fragment exists in the *AG* second intron/enhancer that plays crucial role in the repression of vegetative activity of the chimeric promoter by mediating H3K27 tri-methylation. Bioinformatic analysis reveals that the 100-bp repressive fragment has a GAGA factor binding motif, which is conserved among the species of Solanaceae family, underpinning the importance of this element in the vegetative silencing of *AG* gene.

Singer and colleagues \[[@pone.0230203.ref039]\] reported that 35S enhancer could override the *AGI*-conferred tissue specificity in Arabidopsis, resulting constitutive expression of the AtAGIP controlled gene in the vegetative tissues. We notice that a variant of duplicated enhancer was used in their study. This duplicated 35S enhancer was shown having approximately tenfold higher activity than that of the single 35S enhancer. Furthermore, it could boost the activity of adjacent promoter by several hundredfold \[[@pone.0230203.ref040]\]. In our study, we used the 351 bp fragment (-396 to -46) of 35S promoter to increase the activity of NtAGIP1. GUS activity detection showed that the activity of NtAGIP1 was increased by one- to two-fold. Meanwhile, the promoter maintains its activity in flower organs. Therefore, it is conceivable that the strong activity of duplicated 35S enhancer is hard to be suppressed by the potential repressive elements of AGI. In other words, the ability of repressive elements of tissue-specific promoters to suppress the global activity of a constitutive enhancer depends on the strength of the enhancer used. Consistently, the 35S promoter altered the level and patterns of activity of adjacent tissue- and organ-specific gene promoters, while the similar constitutive Nos promoter that is weaker than the 35S promoter had no effect on these adjacent promoters \[[@pone.0230203.ref041],[@pone.0230203.ref042]\]. Likewise, 35S enhancer could convert the flower-specific promoter PCHS to non-specific gene promoter, while a weaker OCS enhancer was able to increase the activity of PCHS promoter specifically in the targeted tissues \[[@pone.0230203.ref010]\].

Although weak enhancers can increase activity of tissue-specific promoter, it would not be a good choice when strong expression is needed. Using a strong repressive element or *cis*-repressor may benefit overcoming the constitutive activity of strong enhancer (*e*.*g*., 35S) in vegetative tissues. The repressive element of NtAGI-1 we identified is a potential candidate. Du and colleagues used the 163-bp 35S enhancer fragment (-208 to -46) to increase the activity of flower specific CHS promoters that contain vegetative repressive element TACPyAT box. However, the repressive element was unable to suppress the activity of 35S enhancer in vegetative tissues \[[@pone.0230203.ref010],[@pone.0230203.ref043]\]. In our study, the vegetative activity of the longer 351-bp 35S enhancer fragment (-396 to -46) that is responsible for the majority of the 35S promoter strength \[[@pone.0230203.ref033]\] could be suppressed by the repressive element of NtAGI-1, showing a potential of the repressive element in the design of synthetic reproductive promoters.

Adding 35S enhancer can extend the tissue specificity of NtAGIP1 from inner whorls of flower (stamens and carpels) to the outer whorls (sepals and petals), but the activity of 35SNtAGIP1 does not cross the boundary of flower organs. An array of factors is responsible for the repression of *AG* \[[@pone.0230203.ref044],[@pone.0230203.ref045]\]. For example, *APETALA2* is involved in the repressing the expression of *AG* in the outer floral whorls through recruiting the histone deacetylase HDA19, thus preventing gene activation *via* histone deacetylation \[[@pone.0230203.ref023],[@pone.0230203.ref046]\]. Polycomb repressive complex 2 (PRC2) is implicate in the repressing *AG* in the vegetative tissues by mediating H3K27 trimethylation to form epigenetically stable silent chromatin state \[[@pone.0230203.ref037],[@pone.0230203.ref038]\]. PRC2 is evolutionarily conserved \[[@pone.0230203.ref047]--[@pone.0230203.ref049]\]. The recruitment of PRC2 in Arabidopsis relies largely on binding of *trans*-acting factors to *cis* DNA motifs known as polycomb response elements (PREs) \[[@pone.0230203.ref034]--[@pone.0230203.ref036]\]. Importantly, GAGA factor binding motif has been found to be involved in the recruitment of PRC2 in both Arabidopsis and *Drosophila*. Recently, Wu and colleagues reported that a DNA region within Arabidopsis *AG* intron 2 (+2616 to +3348) is involved in the recruitment of PRC2 to represses *AG* expression in leaves *via* the transcribed noncoding RNA \[[@pone.0230203.ref045]\]. They pointed out that the identified DNA region also contains PREs which may recruit PRC2. We found that the GAGA factor binding motif is also included in the region of the AtAGI. Bioinformatic analysis indicates that the GAGA motif is conserved among the Solanaceae family. Furthermore, deletion of the GAGA motif containing 100-bp repressive fragment of NtAGI-1 caused decreased H3K27me3 level and de-repression of the chimeric promoter activity in leaves, suggesting that the GAGA motif may be involved in the recruitment of PRC2 at the *AG* locus for vegetative repression in plants. Thus, our results may inspire studies on the regulation of other floral genes which need to be suppressed so as to allow normal vegetative development \[[@pone.0230203.ref050]\].

In summary, our work constructs a new chimeric flower-specific promoter for plant engineering, and the 100 bp GAGA motif-containing sequence identified here may provide important information to investigate the regulation of *AGAMOUS* genes in plants.

Supporting information {#sec017}
======================

###### Primer sequences used for plasmid construction and PCR identification of transformants.

(XLSX)

###### 

Click here for additional data file.

###### Primer sequences used for ChIP.

(XLSX)

###### 

Click here for additional data file.
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Response to the editor:

Dear Dr. Serena Aceto,

Thanks for the advice. Accordingly, we improved the manuscript as suggested. The main changes in revised manuscript are as followings:

1\. As suggested by reviewers \#1, we conducted chromatin immunoprecipitation (ChIP) assay to confirm this region have H3K27me3 modification. We added Figure 8 to show the new results. The procedure for ChIP assay is added in the section of Materials and methods.

2\. The changes are indicated in the revised version labeled \'Revised Manuscript with Track Changes\'.

3\. The PACE was used to convert figures to meet the figure requirements of PLOS ONE. Thus, all figures submitted before would be replaced with new figures of new format.

4\. Please change the support funding as: the Chinese Ministry of Science and Technology of China (Grant 2016YFD0100505).

Response to Reviewers:

Point to point response

Reviewer \#1:

This manuscript by RuochenLiu et al reports repression function of a 100bp element in AGAMOUS 2nd intron due to possible targeting by PPC2 complex. Using this repression function, the authors showed that GUS signal could be restricted to inflorescence although under 35s enhancer. The result is interesting but with current data, it is not publishable on PLOS one. My concerns are:

1\. The authors showed that the expression of NtAG intron promoter could be enhanced by 35S due to the presence of the 100bp fragment. However, in figure 5, when this repression fragment alone was under 35S enhancer, there is quite some leaky expression in leaves. This raises one question: for what purpose we could use this repression fragment. For instance, is it possible to use the combination of 35s enhancer, 100bp repression fragment and other flower gene promoter (like AP1,AP3) to enhance the expression of certain flower genes? Would be nice if the author could show some in-planta data, even if it is only for AGAMOUS gene.

Response: We identified the 100bp fragment in NtAG intron that contributes the suppression of activity in vegetative tissues. Sandwiched between 35S enhancer and 35S mini promoter, this 100bp fragment produced a 33% decrease of leaky expression in vegetative tissues compared with the controls (a 100bp fragment from up- or down-stream of the fragment), indicating the suppressive effect of the fragment on vegetative expression. We are uncertain whether the 35S enhancer and 100bp repression fragment be able to enhance the promoter activity for other flower genes. It is a good idea to use the combination of 35s enhancer, 100bp repression fragment and other flower gene promoter to enhance the expression of certain flower genes or test if the fragment is only for AGAMOUS gene or for more genes. We find that when the NtAGI-1sequence is longer than 2835bp no GUS expression was detectable in leaves of all transgenic plants (Figure 4), implying that other sequences/elements in NtAGI-1 are also required to restrict the expression of downstream gene in flower organs. In this study, we focus on the 100bp sequence in the NtAG intron. Next, we are going to identify the sequences (or motifs) which work with the 100bp fragment to suppress the promoter activity in leaf, and then use these sequences together to generate new promoters. We really appreciate the reviewer's suggestion.

2\. There are some other strategies to boost gene expression in-vivo, including endogenous promoter driven inducible system or dCas9-based in-vivo activation tool. Compared to the above mentioned methods, usage of 35senhancer has less potential. In this regards, the value of this work is limited.

Response: We agree that dCas9-based tool is a powerful tool that can boost the expression of target genes. However, how to accurately regulate the expression of target genes in target organs is still a problem. In the available systems, the chimeric promoter is a simple strategy. Even in CRISPR- Cas9 era, other strategies still have their rooms in plant biotechnology. In addition to promoter design, our study can also provide information to investigate the regulation of AGAMOUS gene.

3\. Discovery of the GAGA motif containing fragment is of interest to the community. The author should dig a bit more. Is this motif really bound by PRC2? Could the author at least confirm this region is modified by H3K27me3 and the modification level is dynamic across flower development or at least between leaves and flower? Would be very interesting if the author could delete the 100bp base pair by CRISPR tool and see what the genetic effect is.

Response: Thanks for the suggestion. Accordingly, we conducted chromatin immunoprecipitation (ChIP) assay and showed that in the wild-type tobacco the entire NtAGI-1 intron including the 100bp repressive fragment was enriched for H3K27me3. Meanwhile in the GUS positive -2735 cells, H3K27me3 level of the chimeric promoter were much lower than that in the GUS negative -2835 cells. The results indicate the crucial role of GAGA motif in the vegetative repression of AG and the AGI-derived artificial promoters. We add the new data in Figure 8.

4\. Besides, the authors should increase the quality of all the figures. They are too blurry.

Response: This is probably due to the low resolution in submitting. We submit figures with high resolution, hoping that the problem would be resolved.

Reviewer \#2:

The findings detailed in this manuscript is useful for the plant research community. The experiments and results were appropriately documented overall. However, there are grammatical errors that need to be reviewed and corrected throughout the manuscript. Additionally, in the results section, increase in transformation events with strong GUS expression from 15% to 46% was erroneously mentioned as two-fold increase. Please check the details of the results and figures to avoid these types of errors.

Response: Thanks! The error had been corrected. We have carefully edited the manuscript and checked the details of the results and figures.
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: I appreciate the efforts by the authors to address my concern. I am satisfied. Could the author integrate some of the responses they gave in the rebuttal into the manuscript? For example, more details about the potential application of the findings.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Point to point response

Reviewer \#1:

I appreciate the efforts by the authors to address my concern. I am satisfied. Could the author integrate some of the responses they gave in the rebuttal into the manuscript? For example, more details about the potential application of the findings.

Response: Thanks a lot for your kind comments and valuable suggestions. We have integrated some information in the reponse into the revised manuscript. In the Introduction of the revised manuscript (Page 2, Paragraph 1, Line 40-44), we explained the merit of the synthetic promoters. In the Discussion of the revised manuscript (Page 9, Paragraph 4, Line 349-351), we summarize the potential application of the findings in the plant biotechnology and in the investigation of AGAMOUS gene in plants.
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Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.
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With kind regards,

Serena Aceto, Ph.D.

Academic Editor

PLOS ONE

10.1371/journal.pone.0230203.r006

Acceptance letter

Aceto

Serena

Academic Editor

© 2020 Serena Aceto

2020

Serena Aceto

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

27 Feb 2020

PONE-D-19-32760R2

A 100 bp GAGA motif-containing sequence in AGAMOUS second intron is able to suppress the activity of CaMV35S enhancer in vegetative tissues

Dear Dr. Pei:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.
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PLOS ONE Editorial Office Staff
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Dr Serena Aceto
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